India is the world’s largest producer of the anti-malaria drug, hydroxychloroquine, and it’s making more of it in response to endorsements from President Donald Trump. Dr. Shriprakash Kalantri of the Mahatma Gandhi Institute of Medical Sciences in Maharashtra tells host Marco Werman the drug is not a “magic bullet” and asks why fellow Indians are also promoting it.
The story you just read is not locked behind a paywall because listeners and readers like you generously support our nonprofit newsroom. Now more than ever, we need your help to support our global reporting work and power the future of The World. Can we count on you?